Find Clinical Trials
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 years. A randomised, double-blind, multicentre, placebo controlled, phase II/III dose-finding study with a PK/PD characterisation and a 1 year efficacy/safety evaluation.
Servier Protocol Code:
CL2-16257-090
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2011-001292-39
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Heart failure
- IVABRADINE
- S016257
Other study id numbers
Other identification numbers the study may be known by.
- CL2-16257-090